BioAge Labs, Inc. (BIOA) Earnings History
Annual and quarterly earnings data from 2022 to 2025
Loading earnings history...
BIOA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BIOA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 100.0% | -1031.5% | -896.1% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export BIOA earnings history in CSV or JSON format
Free sign-in required to download data
BioAge Labs, Inc. (BIOA) Earnings Overview
As of May 8, 2026, BioAge Labs, Inc. (BIOA) reported trailing twelve-month net income of -$81M, reflecting +66.2% year-over-year growth. The company earned $-2.24 per diluted share over the past four quarters, with a net profit margin of -896.1%.
Looking at the long-term picture, BIOA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$40M in fiscal 2022.
BioAge Labs, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KYMR (-$315M net income, -794.4% margin), RVMD (-$1.37B net income), LNTH ($279M net income, 15.2% margin), BIOA has room to improve margins relative to the peer group. Compare BIOA vs KYMR →
BIOA Earnings vs Peers
Earnings metrics vs comparable public companies
BIOA Historical Earnings Data (2022–2025)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$81M | -13.4% | -$93M | $-2.24 | -896.1% | -1031.5% |
| 2024 | -$71M | -11.4% | -$78M | $-6.63 | - | - |
| 2023 | -$64M | -60.8% | -$48M | $-8.55 | - | - |
| 2022 | -$40M | - | -$40M | $-5.32 | - | - |
See BIOA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BIOA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BIOA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBIOA — Frequently Asked Questions
Quick answers to the most common questions about buying BIOA stock.
Is BIOA growing earnings?
BIOA EPS is $-2.24, with earnings growth accelerating to +66.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-81M.
What are BIOA's profit margins?
BioAge Labs, Inc. net margin is -896.1%, with operating margin at -1031.5%. Below-average margins reflect competitive or cost pressures.
How consistent are BIOA's earnings?
BIOA earnings data spans 2022-2025. The accelerating earnings trend is +66.2% YoY. Historical data enables comparison across business cycles.